Primary vitreoretinal large B-cell lymphoma Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Primary vitreoretinal large B-cell lymphoma.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Yescarta

Kite Pharma, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Yescarta

(axicabtagene ciloleucel)Orphan drugstandard

Kite Pharma, Inc.

CD19-directed Chimeric Antigen Receptor [EPC]

12.1 Mechanism of Action YESCARTA, a CD19-directed genetically modified autologous T cell immunotherapy, binds to CD19-expressing cancer cells and nor...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Primary vitreoretinal large B-cell lymphoma.
Search all trials →

Search clinical trials for Primary vitreoretinal large B-cell lymphoma →

Recent News & Research

No recent news articles indexed yet for Primary vitreoretinal large B-cell lymphoma.
Search PubMed for Primary vitreoretinal large B-cell lymphoma →

Browse all Primary vitreoretinal large B-cell lymphoma news →

Specialist Network

No specialists currently listed for Primary vitreoretinal large B-cell lymphoma.

View all Primary vitreoretinal large B-cell lymphoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰